Edition:
United Kingdom

Ovid Therapeutics Inc (OVID.OQ)

OVID.OQ on NASDAQ Stock Exchange Global Select Market

5.60USD
21 Sep 2018
Change (% chg)

$-0.35 (-5.88%)
Prev Close
$5.95
Open
$5.96
Day's High
$5.96
Day's Low
$5.52
Volume
139,056
Avg. Vol
15,179
52-wk High
$12.36
52-wk Low
$5.52

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.525
Mar '18 0.00 -0.536
FY 2017 Dec '17 0.00 -0.057
Sep '17 0.00 -0.380
Jun '17 0.00 -0.566
Mar '17 0.00 -1.392
FY 2016 Dec '16 0.00 -0.307
Sep '16 0.00 -0.235
Jun '16 0.00 -0.219
Mar '16 0.00 -0.150
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-19 5 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 5 -0.59 -0.55 -0.63 -0.72
Quarter Ending Dec-18 5 -0.60 -0.54 -0.65 -0.78
Year Ending Dec-18 5 -2.25 -2.15 -2.30 -2.75
Year Ending Dec-19 6 -2.55 -2.25 -2.79 -3.23
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) -- 114.98 5.74
Price to Book (MRQ) 2.04 15.51 5.00
Price to Tangible Book (MRQ) 2.04 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 35.96 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 15.19 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.27 12.51
Total Debt to Equity (MRQ) 0.00 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -- -759.68 4.33
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -- -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -- -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,229,030 860,305,024
Net Income/Employee (TTM) -- 3,144,146 101,198,978
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) -- 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.15 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -- 1.79 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -- 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -70.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ovid Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.95 -0.60 53 52
13 Week -13.70 -17.90 27 66
26 Week -- -- -- 80
52 Week -- -- -- 50
YTD -- -- -- 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.10%
# of Holders: 74
Total Shares Held: 7,907,481
3 Mo. Net Change: 615,721
# New Positions: 13
# Closed Positions: 9
# Increased Positions: 46
# Reduced Positions: 22
# Net Buyers: 24
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.